5AM Ventures has plans for $240 million in the biotech investment sector
The 5AM investor has approximately 435 million US dollars at his disposal, and his portfolio includes outstanding innovative companies, including Ambrx, Cleave Biosciences, as well as Relypsa, which plans to place its shares on the market soon.
25.10.2013